title: Synthesis, DNA binding, footprinting and in vitro antitumour studies of a meta-hydroxy analogue of Hoechst 33258.
abstract: An analogue of Hoechst 33258, bearing a phenolic hydroxyl group in the meta rather than para position, was designed using molecular graphics to introduce hydrogen-bonding potentials between this OH group and the C = O group of cytosine-9 and the NH2 group of guanine-4', of the opposite strand of the B-DNA duplex, d(CGCGAATTCGCG)2. This derivative (meta-Hoechst) was synthesized in seven steps and characterized. Its binding to DNA was assessed by measurements of melting temperatures (Tm) and found to be similar in strength and AT preference to the parent Hoechst 33258 at this gross level. The AT preference of meta-Hoechst and Hoechst 33258 was probed further using hydroxyl radical footprinting on the tyrT DNA fragment, for which clear footprints were detected at AAT, AAA and ATAT runs, as for netropsin and distamycin. Hydroxyl radical footprinting was carried out on a trimer of CGCGAATTCGCG cloned into a longer DNA fragment, for which clear footprints for both Hoechst 33258 and meta-Hoechst were detected in regions with four or more contiguous AT base pairs. Three cell lines derived from haematological malignancies were more sensitive to both Hoechst 33258 and meta Hoechst than lines derived from solid tumours, but there was no significant difference between the activity of these two Hoechst derivatives.
authors.affiliation: Department of Pharmacy, University of Manchester, UK.
authors.forename: S E
authors.initials: SE
authors.lastname: Ebrahimi
authors.forename: M C
authors.initials: MC
authors.lastname: Bibby
authors.forename: K R
authors.initials: KR
authors.lastname: Fox
authors.forename: K T
authors.initials: KT
authors.lastname: Douglas
mesh_terms: D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000633:toxicity; D018906:Antineoplastic Agents, Alkylating / Q000737:chemistry*; D001483:Base Sequence; D001562:Benzimidazoles / Q000737:chemistry; D001665:Binding Sites; D006690:Bisbenzimidazole / Q000031:analogs & derivatives*; D018736:DNA Adducts / Q000737:chemistry; D018983:DNA Footprinting; D015251:Epirubicin / Q000633:toxicity; D006801:Humans; D017665:Hydroxyl Radical / Q000737:chemistry; D008969:Molecular Sequence Data; D009691:Nucleic Acid Denaturation; D013329:Structure-Activity Relationship; D014407:Tumor Cells, Cultured
chemical_list: D000903:Antibiotics, Antineoplastic; D018906:Antineoplastic Agents, Alkylating; D001562:Benzimidazoles; D018736:DNA Adducts; D017665:Hydroxyl Radical; D015251:Epirubicin; D006690:Bisbenzimidazole